A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

Param NJ, Arceci E, Fiorentino F, Pignata L, Torre D, Gutiérrez-Trejo N, Fong JY, Goy PA, Han BY, Lambona C, Di Bello E, Castiello C, Barone M, Schwarz M, Arrowsmith C, Ito K, Scherle P, Wee DKB, Ndoye S, Tabaglio T, Jeyasekharan AD, Lakshmanan M, Cirilli R, Habisch H, Madl T, Mattevi A, Valente S, Mai A, Guccione E